Xitian (Shanghai) Biotechnology Overview
- Year Founded
-
2023
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
2
Xitian (Shanghai) Biotechnology General Information
Description
Provider of bioactive ingredient development designed to advance health and wellness through natural compounds. The company offers proprietary extraction technologies, high-purity bioactive substances, and customized formulation services, enabling nutraceutical, pharmaceutical, and cosmetic manufacturers to enhance product efficacy and support innovation in health-related applications.
Contact Information
Corporate Office
- 3rd Floor, Building L9, Lane 218, Weihang Road
- Baoshan District
- Shanghai, 201900
- China
Corporate Office
- 3rd Floor, Building L9, Lane 218, Weihang Road
- Baoshan District
- Shanghai, 201900
- China
Xitian (Shanghai) Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 09-Jan-2025 | Completed | Generating Revenue |
Xitian (Shanghai) Biotechnology Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Shanghai Shique Investment Management | Growth/Expansion | Minority | ||
| Yisan Capital | Venture Capital | Minority |
Xitian (Shanghai) Biotechnology FAQs
-
When was Xitian (Shanghai) Biotechnology founded?
Xitian (Shanghai) Biotechnology was founded in 2023.
-
Where is Xitian (Shanghai) Biotechnology headquartered?
Xitian (Shanghai) Biotechnology is headquartered in Shanghai, China.
-
What industry is Xitian (Shanghai) Biotechnology in?
Xitian (Shanghai) Biotechnology’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Xitian (Shanghai) Biotechnology a private or public company?
Xitian (Shanghai) Biotechnology is a Private company.
-
What is Xitian (Shanghai) Biotechnology’s current revenue?
The current revenue for Xitian (Shanghai) Biotechnology is .
-
Who are Xitian (Shanghai) Biotechnology’s investors?
Shanghai Shique Investment Management and Yisan Capital have invested in Xitian (Shanghai) Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process